Here’s Why Acceleron Pharma Stock Fell 12% in September [The Motley Fool]
Acceleron Pharma Inc. (XLRN)
Last acceleron pharma inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.acceleronpharma.com/investor-relations
Company Research
Source: The Motley Fool
Here’s Why Acceleron Pharma Stock Fell 12% in September What happened Shares of Acceleron Pharma Global Market Intelligence biotech So what Interestingly, the drug increased FSHD is characterized by muscle weakness, so gaining strength, rather than just muscle, is obviously important. Given the disappointing phase data, Acceleron doesn't plan to continue development of ACE-08 in patients with FSHD. Image source: Getty Images. Now what Acceleron Pharma is also testing ACE-08 in Charcot-Marie-Tooth (CMT) disease, a group of disorders that affect nerves, which results in muscle atrophy and weakness. The phase study is expected to read out in the first quarter of next year. Based on the FSHD study, it's possible that the drug might be helping patients grow muscles that aren't functional, although management noted that CMT has a different pathophysiology than FSHD, so perhaps Acceleron will see different results. Fortunately, these are midstage studies that are relatively cheap to run c
Show less
Read more
Impact Snapshot
Event Time:
XLRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XLRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XLRN alerts
High impacting Acceleron Pharma Inc. news events
Weekly update
A roundup of the hottest topics